Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Genetic Services Laboratory, |
RCV000499942 | SCV000597704 | uncertain significance | not specified | 2016-01-22 | criteria provided, single submitter | clinical testing | |
| Revvity Omics, |
RCV003139708 | SCV003822865 | uncertain significance | not provided | 2023-09-06 | criteria provided, single submitter | clinical testing | |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV000499942 | SCV004038452 | uncertain significance | not specified | 2023-08-08 | criteria provided, single submitter | clinical testing | Variant summary: TTN c.16901A>C (p.Glu5634Ala) results in a non-conservative amino acid change located in the I-band region of the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 247616 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.16901A>C in individuals affected with Dilated Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
| Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000499942 | SCV006069892 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing |